WuXi Biologics launches $200m debut borrowing
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
Asia

WuXi Biologics launches $200m debut borrowing

Pan Yue
March 27, 2019 09:00 AM
Pills_230px

Chinese pharmaceuticals company WuXi Biologics has launched a debut offshore loan of $200m through sole lead Standard Chartered.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansChinaHong Kong SARAsiaGreater ChinaStandard CharteredNortheast AsiaLoans and High YieldAsia PacificLevFinLeveraged LoansEmerging Market LoansLevFin Leveraged LoansEmerging MarketsSRI
PY
Pan Yue
Loans reporter GlobalCapital Asia
Contact
Gift this article